Citation Impact

Citing Papers

Phosphorylation of ULK1 (hATG1) by AMP-Activated Protein Kinase Connects Energy Sensing to Mitophagy
2010 StandoutScience
Somatic Mutations Lead to an Oncogenic Deletion of Met in Lung Cancer
2006
MET Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling
2007 StandoutScience
Functional specialization of β-arrestin interactions revealed by proteomic analysis
2007 StandoutNobel
Response to MET Inhibitors in Patients with Stage IV Lung Adenocarcinomas Harboring MET Mutations Causing Exon 14 Skipping
2015
TOR Signaling in Growth and Metabolism
2006 Standout
Comprehensive genomic characterization of head and neck squamous cell carcinomas
2015 StandoutNature
Differentiation of tumour-promoting stromal myofibroblasts by cancer exosomes
2014
G Protein–Coupled Receptor Kinase Mediates Desensitization of Norepinephrine-Induced Ca2+ Channel Inhibition
1996 StandoutNobel
Altered Beta-adrenergic Receptor Gene Regulation and Signaling in Chronic Heart Failure
2001
mTOR Signaling in Growth Control and Disease
2012 Standout
Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex
2008
The Tuberous Sclerosis Complex
2006 Standout
Dramatic effect of sirolimus on renal angiomyolipomas in a patient with tuberous sclerosis complex
2007
Oncogene addiction: setting the stage for molecularly targeted cancer therapy
2007
Cytoskeleton/stretch‐activated ion channel interaction regulates myogenic differentiation of skeletal myoblasts
2007
Calcium's Role in Mechanotransduction during Muscle Development
2014 Standout
Bone marrow cells regenerate infarcted myocardium
2001 StandoutNature
Subtype-specific β-adrenoceptor signaling pathways in the heart and their potential clinical implications
2004
The biology and management of non-small cell lung cancer
2018 StandoutNature
Lung Cancer
2008 Standout
Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency
2009 Standout
Loss of the Tuberous Sclerosis Complex Tumor Suppressors Triggers the Unfolded Protein Response to Regulate Insulin Signaling and Apoptosis
2008
Percutaneous Repair or Surgery for Mitral Regurgitation
2011 Standout
The PDZ Binding Motif of the β1 Adrenergic Receptor Modulates Receptor Trafficking and Signaling in Cardiac Myocytes
2002 StandoutNobel
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Anti–β1-adrenergic receptor antibodies and heart failure: causation, not just correlation
2004 StandoutNobel
Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy
2005 Standout
Sirolimus for Angiomyolipoma in Tuberous Sclerosis Complex or Lymphangioleiomyomatosis
2008 Standout
HEART FAILURE WITH NORMAL SYSTOLIC FUNCTION
2000
Efficacy and Safety of Onartuzumab in Combination With First-Line Bevacizumab- or Pemetrexed-Based Chemotherapy Regimens in Advanced Non-Squamous Non–Small-Cell Lung Cancer
2016
mTOR Signaling in Growth, Metabolism, and Disease
2017 Standout
Animal Models of Heart Failure Recent Developments and Perspectives
1997
Regulation of β-Adrenergic Receptor Signaling by S-Nitrosylation of G-Protein-Coupled Receptor Kinase 2
2007 StandoutNobel
Endoplasmic Reticulum Stress and the Inflammatory Basis of Metabolic Disease
2010 Standout
Lymphangioleiomyomatosis — a wolf in sheep’s clothing
2012
The LKB1–AMPK pathway: metabolism and growth control in tumour suppression
2009
Proteomic, Functional, and Domain-Based Analysis of In Vivo 14-3-3 Binding Proteins Involved in Cytoskeletal Regulation and Cellular Organization
2004
Heart???lung interactions
2007
Myocardial beta-adrenergic receptor function during the development of pacing-induced heart failure.
1993
Communication by Extracellular Vesicles: Where We Are and Where We Need to Go
2016 Standout
β-Arrestin–mediated β1-adrenergic receptor transactivation of the EGFR confers cardioprotection
2007 StandoutNobel
AKT/PKB Signaling: Navigating the Network
2017 Standout
Use of a Continuous-Flow Device in Patients Awaiting Heart Transplantation
2007 Standout
Trends in Prevalence and Outcome of Heart Failure with Preserved Ejection Fraction
2006 Standout
The PI3K Pathway in Human Disease
2017 Standout
PDGFRs are critical for PI3K/Akt activation and negatively regulated by mTOR
2007
Ras, PI(3)K and mTOR signalling controls tumour cell growth
2006 StandoutNature
Tuberous sclerosis: a GAP at the crossroads of multiple signaling pathways
2005
VEGF in Signaling and Disease: Beyond Discovery and Development
2019 Standout
Inhibition of Spontaneous β2-Adrenergic Activation Rescues β1-Adrenergic Contractile Response in Cardiomyocytes Overexpressing β2-Adrenoceptor
2000 StandoutNobel
Mammalian G-protein function in vivo: New insights through altered gene expression
2006
β-ADRENERGIC RECEPTOR REGULATION IN THE HEART IN PATHOPHYSIOLOGIC STATES: ABNORMAL ADRENERGIC RESPONSIVENESS IN CARDIAC DISEASE
1991
Linkage of β1-adrenergic stimulation to apoptotic heart cell death through protein kinase A–independent activation of Ca2+/calmodulin kinase II
2003 StandoutNobel
Principles of Cancer Therapy: Oncogene and Non-oncogene Addiction
2009 Standout
Myocarditis
2009 Standout
Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms
2010 Standout
Heart size-independent analysis of myocardial function in murine pressure overload hypertrophy
2002
Dual modulation of cell survival and cell death by β 2 -adrenergic signaling in adult mouse cardiac myocytes
2001 StandoutNobel
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
2005 Standout
Toxic Potential of Materials at the Nanolevel
2006 StandoutScience
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Pacing-Induced Heart Failure in Dogs Enhances the Expression of p53 and p53-Dependent Genes in Ventricular Myocytes
1998
Feedback inhibition of Akt signaling limits the growth of tumors lacking Tsc2
2005
Inhibition of the Met Receptor in Mesothelioma
2005
Stoichiometry and Compartmentation in G Protein-Coupled Receptor Signaling: Implications for Therapeutic Interventions Involving Gs
2000
2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009
Cardiac hypertrophy and sudden death in mice with a genetically clamped renin transgene
2004 StandoutNobel
Myocyte Adrenoceptor Signaling Pathways
2003 StandoutScienceNobel
Systems analysis of PKA-mediated phosphorylation gradients in live cardiac myocytes
2006 StandoutNobel
Higher versus Lower Positive End-Expiratory Pressures in Patients with the Acute Respiratory Distress Syndrome
2004 Standout
Genetic Classification of Lung Adenocarcinoma Based on Array-Based Comparative Genomic Hybridization Analysis: Its Association with Clinicopathologic Features
2005
Linkage of β1-adrenergic stimulation to apoptotic heart cell death through protein kinase A–independent activation of Ca2+/calmodulin kinase II
2003 StandoutNobel
Critical roles for the TSC-mTOR pathway in β-cell function
2009
The TSC1–TSC2 complex: a molecular switchboard controlling cell growth
2008 Standout
G PROTEIN–COUPLED RECEPTOR KINASES
1998 StandoutNobel
Role of β-adrenergic receptor signaling and desensitization in heart failure: new concepts and prospects for treatment
2006
Autophagy and Metabolism
2010 StandoutScience
Anti–β1-adrenergic receptor antibodies and heart failure: causation, not just correlation
2004 StandoutNobel
MET Tyrosine Kinase Inhibitor Crizotinib (PF-02341066) Shows Differential Antitumor Effects in Non-small Cell Lung Cancer According to MET Alterations
2011
Apoptosis of Cardiac Myocytes in Gsα Transgenic Mice
1999
MET Exon 14 Mutations in Non–Small-Cell Lung Cancer Are Associated With Advanced Age and Stage-Dependent MET Genomic Amplification and c-Met Overexpression
2016
mTORC1 Promotes Denervation-Induced Muscle Atrophy Through a Mechanism Involving the Activation of FoxO and E3 Ubiquitin Ligases
2014
A selective small molecule inhibitor of c-Met, PHA-665752, reverses lung premalignancy induced by mutant K-ras
2008
The Cerebellum-Specific Munc13 Isoform Munc13-3 Regulates Cerebellar Synaptic Transmission and Motor Learning in Mice
2001 StandoutNobel

Works of Alan S. Lader being referenced

Functional Expression and Mutations of c-Met and Its Therapeutic Inhibition with SU11274 and Small Interfering RNA in Non–Small Cell Lung Cancer
2005
Characterization of Na+-permeable Cation Channels in LLC-PK1 Renal Epithelial Cells
2004
Efficacy of a rapamycin analog (CCI‐779) and IFN‐γ in tuberous sclerosis mouse models
2004
A mouse model of cardiac rhabdomyoma generated by loss of Tsc1 in ventricular myocytes
2004
Alterations in left ventricular diastolic function in conscious dogs with pacing-induced heart failure.
1992
Effects of pericardial pressure on systemic and coronary hemodynamics in dogs
1995
Cardiac G overexpression enhances L-type calcium channels through an adenylyl cyclase independent pathway
1998
Changes in diastolic cardiac function in developing and stable perinephritic hypertension in conscious dogs.
1991
Isoproterenol-induced alterations in myocardial blood flow, systolic and diastolic function in conscious dogs with heart failure.
1989
Role of gelsolin in the actin filament regulation of cardiac L-type calcium channels
1999
Rankless by CCL
2026